International Journal of
Reproductive Biomedicine
Mon, Jul 22, 2024
[Archive]
Volume 22, Issue 1 (January 2024)
IJRM 2024, 22(1): 69-80 |
Back to browse issues page
Ethics code: IR.TUMS.IKHC.REC.1401.215
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Hantoushzadeh S, Behzadian A, Hasheminejad M M, Hasheminejad F, Helal Birjandi A, Akbari M et al . Aspirin administration from early pregnancy versus initiation after 11 weeks of gestation for prevention of pre-eclampsia in high-risk pregnant women: Study protocol for randomized controlled trial. IJRM 2024; 22 (1) :69-80
URL: http://ijrm.ir/article-1-3231-en.html
URL: http://ijrm.ir/article-1-3231-en.html
Sedigheh Hantoushzadeh1 
, Arezoo Behzadian * 2, Mohammad Mehdi Hasheminejad3 , Faezeh Hasheminejad4 , Alireza Helal Birjandi5 , Mojtaba Akbari6 , Marjan Ghaemi7
, Arezoo Behzadian * 2, Mohammad Mehdi Hasheminejad3 , Faezeh Hasheminejad4 , Alireza Helal Birjandi5 , Mojtaba Akbari6 , Marjan Ghaemi7
1- Vali-E-Asr Reproductive Health Research Center, Family Health Research Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
2- Department of Perinatology, Vali-E-Asr Hospital, Imam Khomeini Hospital Complex, Tehran, Iran. ,dr.a.behzadian56@gmail.com
3- Iran University of Medical Sciences, Tehran, Iran.
4- Asklepios Psychiatry Lower Saxony GmbH, Asklepios Specialist Clinic, Gottingen, Germany.
5- Hannover Medical School, Clinic for Urology, Hannover, Germany.
6- Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medicine Sciences, Isfahan, Iran.
7- Vali-E-Asr Hospital, Imam Khomeini Hospital Complex, Iran.
2- Department of Perinatology, Vali-E-Asr Hospital, Imam Khomeini Hospital Complex, Tehran, Iran. ,
3- Iran University of Medical Sciences, Tehran, Iran.
4- Asklepios Psychiatry Lower Saxony GmbH, Asklepios Specialist Clinic, Gottingen, Germany.
5- Hannover Medical School, Clinic for Urology, Hannover, Germany.
6- Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medicine Sciences, Isfahan, Iran.
7- Vali-E-Asr Hospital, Imam Khomeini Hospital Complex, Iran.
Abstract: (187 Views)
Background: Pre-eclampsia (PE) is a multiorgan disorder that affects 2-5% of all pregnant women. Present recommendations for when to start aspirin in high-risk women are after 11 wk of gestation.
Objective: We present a protocol to investigate the effectiveness of aspirin use from early pregnancy, which is a randomized controlled trial to assess whether prescribed low-dose aspirin from early pregnancy reduces the prevalence of early and late-onset PE. Additionally, to compare the effectiveness of aspirin administration before and after 11 wk in reducing the occurrence of PE?
Materials and Methods: All pregnancies at risk of PE, according to demographic and midwifery history, who are referred to the Maternal-Fetal Clinic of Tehran University hospital, Tehran, Iran were invited to take part in the trial. The outcomes of pregnancy and newborns will be gathered and analyzed. The first registration for the pilot study was in January 2023, and the participants were recognized as high-risk for PE. In addition, enrollment in the main study will begin as of October 2023.
Objective: We present a protocol to investigate the effectiveness of aspirin use from early pregnancy, which is a randomized controlled trial to assess whether prescribed low-dose aspirin from early pregnancy reduces the prevalence of early and late-onset PE. Additionally, to compare the effectiveness of aspirin administration before and after 11 wk in reducing the occurrence of PE?
Materials and Methods: All pregnancies at risk of PE, according to demographic and midwifery history, who are referred to the Maternal-Fetal Clinic of Tehran University hospital, Tehran, Iran were invited to take part in the trial. The outcomes of pregnancy and newborns will be gathered and analyzed. The first registration for the pilot study was in January 2023, and the participants were recognized as high-risk for PE. In addition, enrollment in the main study will begin as of October 2023.
Keywords: Pre-eclampsia, Aspirin, Color doppler ultrasonography, Pregnancy, First trimester, Pregnancy-associated plasma protein-A.
Type of Study: Original Article |
Subject:
Pregnancy Health
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
